MORGAN NAYLOR: Open Payments
NPI 1942734454 · PORT RICHEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,392 in 53 payments from 14 companies in 2025. Trend: 2023 $1,828 · 2024 $3,163 · 2025 $2,392
Food & beverage: $1,334Consulting: $1,058
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 16 | $1,346 |
| ABBVIE INC. | 9 | $375 |
| UCB, Inc. | 6 | $203 |
| Incyte Corporation | 5 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $68 |
| Janssen Biotech, Inc. | 3 | $63 |
| Amgen Inc. | 2 | $45 |
| PFIZER INC. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| GENZYME CORPORATION | 1 | $33 |
Products named: Bimzelx, NEMLUVIO, SKYRIZI, OPZELURA, DUPIXENT, TREMFYA, OTEZLA, CIBINQO.
Industry payments across FL — which companies pay providers there.
